Scholars@Duke
Natalie Katz

Natalie Katz

Assistant Professor of Pediatrics
Pediatrics, Neurology

Selected Publications

Predictors of respiratory decline in neuromuscular disorders.

Journal Article Respir Med · January 2026 Neuromuscular diseases (NMDs) constitute a heterogeneous group of genetic and acquired disorders that lead to progressive muscle weakness. When the respiratory muscles are involved, impaired ventilation and ineffective airway clearance become a major sourc ... Full text Link to item Cite

Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophy.

Journal Article Neuromuscul Disord · September 2025 Gene transfer therapy represents a major advancement in the treatment of patients with Duchenne muscular dystrophy (DMD). As clinical use expands, there is an urgent need for standardized, evidence and practice-informed guidelines to ensure safe and equita ... Full text Link to item Cite

Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years.

Journal Article J Physiol · October 2024 Duchenne muscular dystrophy (DMD) results in a progressive loss of functional skeletal muscle mass (MM) and replacement with fibrofatty tissue. Accurate evaluation of MM in DMD patients has not previously been available. Our objective was to measure MM usi ... Full text Link to item Cite

Predictors of functional outcomes in patients with facioscapulohumeral muscular dystrophy.

Journal Article Brain · December 16, 2021 Facioscapulohumeral muscular dystrophy (FSHD) is one of the most prevalent muscular dystrophies characterized by considerable variability in severity, rates of progression and functional outcomes. Few studies follow FSHD cohorts long enough to understand p ... Full text Link to item Cite

The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis.

Journal Article Neuropharmacology · January 2021 The beneficial effects of acetylcholinesterase inhibitors for the treatment of myasthenia gravis (MG) was a major discovery that came about through one young physician putting together a string of previous observations. To understand how this discovery cam ... Full text Link to item Cite

Deletion of the insulin receptor in sensory neurons increases pancreatic insulin levels.

Journal Article Exp Neurol · July 2018 Insulin is known to have neurotrophic properties and loss of insulin support to sensory neurons may contribute to peripheral diabetic neuropathy (PDN). Here, genetically-modified mice were generated in which peripheral sensory neurons lacked the insulin re ... Full text Link to item Cite

Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.

Journal Article Neuroscience · January 29, 2015 Diabetic peripheral neuropathy is a common complication of diabetes mellitus, and a significant proportion of individuals suffer debilitating pain that significantly affects their quality of life. Unfortunately, symptomatic treatment options have limited e ... Full text Link to item Cite

Salt stress in Desulfovibrio vulgaris Hildenborough: an integrated genomics approach.

Journal Article J Bacteriol · June 2006 The ability of Desulfovibrio vulgaris Hildenborough to reduce, and therefore contain, toxic and radioactive metal waste has made all factors that affect the physiology of this organism of great interest. Increased salinity is an important and frequent fluc ... Full text Link to item Cite